Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) EBITDA Margin (2020 - 2025)

iSpecimen (ISPC) has 6 years of EBITDA Margin data on record, last reported at 2608.68% in Q3 2025.

  • For Q3 2025, EBITDA Margin fell 255459.0% year-over-year to 2608.68%; the TTM value through Sep 2025 reached 343.99%, down 25427.0%, while the annual FY2024 figure was 134.52%, 2273.0% down from the prior year.
  • EBITDA Margin reached 2608.68% in Q3 2025 per ISPC's latest filing, down from 146.85% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 31.81% in Q1 2021 and bottomed at 2608.68% in Q3 2025.
  • Average EBITDA Margin over 5 years is 246.6%, with a median of 93.64% recorded in 2022.
  • Peak YoY movement for EBITDA Margin: soared 14552bps in 2024, then plummeted -255459bps in 2025.
  • A 5-year view of EBITDA Margin shows it stood at 78.26% in 2021, then rose by 8bps to 72.31% in 2022, then crashed by -54bps to 111.49% in 2023, then plummeted by -268bps to 409.81% in 2024, then tumbled by -537bps to 2608.68% in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 2608.68% in Q3 2025, 146.85% in Q2 2025, and 156.82% in Q1 2025.